SkIN Canada Research Map​
Lab Info
Name:
Biobank LOEX
Principal investigator:
Ms. Veronique Moulin
Location:
Quebec, Quebec
Contact:
Veronique Moulin
veronique.moulin@fmed.ulaval.ca
Objective/description
The advancement of biomedical research including regenerative medicine, tissue engineering reconstruction of different tissues and organs as well as the understanding of physiological, pathophysiological mechanisms and pharmacotoxicological and cosmetological analyzes.
Collection Details
Skin conditions represented:
Anatomic sites:
Specimen types:
Lab Info
Name:
Piguet Lab
Principal investigator:
Dr. Vincent Piguet
Location:
Toronto, Ontario
Contact:
David Croitoru
David.croitoru@mail.utoronto.ca
Objective/description
We are engaged in translational research of inflammatory dermatoses and perturbation of immune regulation and microbial communities at associated disease sites.
Collection Details
Skin conditions represented:
Anatomic sites:
Specimen types:
Lab Info
Name:
CTTB Biobank and Registry for Atopic dermatitis
Principal investigator:
Dr. Carolyn Jack
Location:
Montreal, Quebec
Contact:
Gaurav Isola
gaurav.isola@mail.mcgill.ca
Objective/description
The Transdisciplinary Centre for Biological Therapies (Centre Transdisciplinaire de Thérapies Biologiques or CTTB) is a multidisciplinary, integrated approach for patients who are receiving therapies directed at the immune system. The CTTB Biobank and Registry for Atopic dermatitis has been created to collect and store blood, skin tissue and other types of biological samples, as well as clinical information, for current and future research purposes.
Objectives:
To identify the impact of various treatments for dermatitis on patient symptoms, quality of life and disease outcome.
To characterize (including potential sequencing) skin lesions and matched normal tissues at the molecular and cellular level (the cells, the DNA, RNA and proteins, as well as their regulatory factors), to help better understand disease biology, prognosis and response to therapy, with a potential to identify new targets for improved treatments.
To characterize cells, proteins and genetic material (RNA and DNA) in the blood or other bodily fluids to identify characteristics that may act to identify specific kinds of skin diseases, or to predict response to therapy or disease outcome.
To characterize biomarkers, including those related to microbiome (bacteria that live on or in humans) to identify potential disease markers, markers of response to therapy or prognostic markers.
Collection Details
Skin conditions represented:
Anatomic sites:
Specimen types:
This is a test